What Genes Influence BPA Sensitivity and Health Risks?

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on genetics & health. Browse all Genetics & Health education

Bisphenol A (BPA) is a chemical used in some plastics and resins, and nearly everyone carries measurable traces. Yet the health impact of the same exposure varies widely from person to person. A meaningful reason is genetic: the enzymes that break BPA down and the receptors it acts on differ between individuals. Understanding which genes influence BPA processing helps explain why sensitivity is not one-size-fits-all.

Why do people react differently to BPA?

BPA does not linger long in the body — it is chemically tagged and excreted, mostly within a day. How efficiently that happens depends on your "phase II" detoxification enzymes. It also acts weakly on estrogen receptors, so how strongly it signals depends on your hormone-pathway genes. Variation in both sets of genes means one person clears and shrugs off an exposure that measurably affects another. This is biology, not a defect.

Phase II detoxification: UGT2B15 and SULT1A1

The body neutralizes BPA mainly by attaching sugar or sulfate groups so it can be flushed out. Glucuronidation is handled largely by UGT2B15, and sulfation by SULT1A1. Common variants in these genes change enzyme activity. A lower-activity SULT1A1 or UGT2B15 variant can mean BPA is conjugated and cleared more slowly, leaving more of the active, unbound chemical circulating for a given exposure. These are the front-line pathways determining BPA burden.

The glutathione pathway: GSTM1 and GSTT1

A second detox layer involves glutathione conjugation, driven in part by the GSTM1 and GSTT1 genes. A large fraction of people carry "null" versions — complete deletions — of one or both, leaving them without that enzyme entirely. Reduced glutathione-pathway capacity is broadly associated with higher susceptibility to oxidative and chemical stress, and it is one reason environmental-chemical sensitivity clusters in some families.

Estrogenic effects and COMT

Because BPA is a weak estrogen mimic, the genes that govern estrogen signaling and metabolism matter too. COMT (catechol-O-methyltransferase) helps clear catechol estrogens, and its well-studied Val158Met variant lowers enzyme activity. Estrogen-receptor genes such as ESR1 shape how strongly estrogenic signals are received. Variation here influences how the body responds to endocrine-active exposures generally — another axis of individual sensitivity.

What your genes reveal — and reducing exposure

Pathway-level genetic insight puts this in context. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including detoxification and hormone-pathway variants like those above. It does not diagnose "BPA toxicity" or measure your BPA level — a lab biomarker test does that. What it offers is understanding of your detox and estrogen pathways, so exposure-reduction choices are informed. Practical, evidence-based steps apply to everyone: favor fresh over canned foods, avoid heating plastics, and choose BPA-free products. A qualified healthcare provider interprets any genetic context alongside your history. PlexusDx tells you about your biology; it does not tell you what to put in your body.

Frequently Asked Questions

Which genes affect how the body handles BPA?

Detoxification genes UGT2B15 and SULT1A1 tag BPA for excretion, GSTM1 and GSTT1 support glutathione conjugation, and hormone-pathway genes like COMT and ESR1 shape estrogenic signaling. Variants in these genes influence how quickly BPA is cleared and how strongly it acts, creating individual differences in sensitivity.

Can a genetic test measure my BPA levels?

No. A genetic test reports pathway-level tendencies in detoxification and hormone signaling — it does not measure BPA in your body. Quantifying actual exposure requires a specific lab biomarker test ordered and interpreted by a qualified healthcare provider, not a DNA report.

Does having a GSTM1 deletion make BPA dangerous for me?

Not by itself. GSTM1-null genotypes are common and are associated with reduced glutathione-pathway capacity, one factor in chemical sensitivity. It is a general tendency, not a diagnosis or a prediction of harm. Overall exposure, other detox genes, and lifestyle all contribute to individual risk.

How can I reduce BPA exposure regardless of my genetics?

Everyone benefits from the same evidence-based steps: favor fresh or frozen over canned foods, avoid microwaving or heating food in plastic, choose BPA-free containers, and reduce handling of thermal receipts. These reduce exposure independently of your detox-gene variants and require no testing to adopt.

Curious how your own biology maps to these pathways? The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across a single at-home saliva sample, giving you pathway-level context to bring to a qualified provider. Know your genetics; don't guess.

This article is part of the PlexusDx Education Hub. Browse all Genetics & Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.